131
RLBD continued: fewer shareholders we do not always have the bid support that we would like, however the other side of that coin is that when buying comes in the stock can be quick to move up.
CIM: Do you have a lot of short sellers in your stock? If yes why?
RLBD: Throughout 2017 RLBD experienced several periods of short selling but this is likely due to the lack of fundamentals. We anticipate correcting the balance sheet and growing revenue in line with our market cap which should minimize short interest in RLBD in both the short and long term.
CIM: What is your Investor Relations strategy for 2018?
RLBD: Since RLBD was transitioning into the Legal Cannabis and Hemp space in 2017 we did not invest heavily into Investor Relations. But ow that we have completed two acquisitions, launched and licensed CBD Pharmacy and will soon launch Omega Hemp Water we will be communicating on a regular basis with these audiences so that RLBD becomes known to Cannabis investors and the financial community as a whole.
CIM: Would you eventually be an acquisition candidate for the larger consumer packaging companies?
RLBD: One of the best parts of being public is that we don’t necessarily have to engineer an acquisition to provide our shareholders an exit strategy. However, having said that, emerging markets tend to consolidate so as the next level of brand owners and
retailers enter the market place we expect
that one or more of RLBD’s brands will be
appealing acquisition targets.